default author photo

Leonardo Provenzano

Fondazione IRCCS Istituto Nazionale dei Tumori

Via Giacomo Venezian, 1

Milano MI, 20133

Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori

SCHOLARLY PAPERS

1

DOWNLOADS

56

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2

Number of pages: 34 Posted: 12 Sep 2025
Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, Giuseppe Curigliano, Mario Giuliano, Andrea Botticelli, Matteo Lambertini, Rizzo Gianpiero, Rebecca Pedersini, Marianna Sirico, Nicla La Verde, Alessandra Gennari, Alberto Zambelli, Angela Toss, Marta Piras, Monica Giordano, Barbara Tagliaferri, Daniele Generali, Donata Sartori, Giuseppe Fotia, Matteo De Monte, Francesca Ligorio and Flavia Jacobs
Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Università di Padova - Dipartimento di Scienze Chirurgiche, European Institute of Oncology (IEO) IRCCS - Division of New Drugs and Early Drug Development for Innovative Therapies, Baylor College of Medicine, Sapienza University of Rome, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), Fondazione IRCCS Policlinico San Matteo, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST Papa Giovanni XXIII, affiliation not provided to SSRN, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, Azienda Socio Sanitaria Territoriale Lariana, affiliation not provided to SSRN, Azienda Socio Sanitaria Territoriale (ASST) Cremona, affiliation not provided to SSRN, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori and Fondazione IRCCS Istituto Nazionale dei Tumori
Downloads 56 (1,041,696)

Abstract:

Loading...

HR+/HER2- advanced breast cancer, CDK4/6 inhibitors, Real-world, progression-free survival, Lobular histology, PALMARES-2